Suchergebnisse - "Best, Jennie H"

PubPharm (58)

31

Estimating the Cost of Illness of Giant Cell Arteritis in the United States

enthalten in: Rheumatology and therapy | 2017

von Babigumira, J. | Li, M. | Boudreau, D. | +2

32

Estimating the Cost of Illness of Giant Cell Arteritis in the United States

enthalten in: Rheumatology and therapy | 2017

von Babigumira, J. | Li, M. | Boudreau, D. | +2

33

Comparison of trajectories of self-monitored glucose levels by hypoglycemia status over 52 weeks of treatment with insulin glargine or exenatide once weekly

enthalten in: Journal of diabetes | 2016

von Paul, S. | Agbeve, J. | Maggs, D. | +1

34

Assessing Methotrexate Adherence in Rheumatoid Arthritis: A Cross-Sectional Survey

enthalten in: Rheumatology and therapy | 2015

von DiBenedetti, D. | Zhou, X. | Reynolds, M. | +2

35

Dynamic risk factors associated with non-severe hypoglycemia in patients treated with insulin glargine or exenatide once weekly

enthalten in: Journal of diabetes | 2015

von Paul, S. | Maggs, D. | Klein, K. | +1

36

The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes : a retrospective observational study

enthalten in: Cardiovascular diabetology | 2015

von Paul, S. | Klein, K. | Maggs, D. | +1

37

The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study

enthalten in: Cardiovascular diabetology | 2015

von Paul, S. | Klein, K. | Maggs, D. | +1

38

The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study

enthalten in: Cardiovascular diabetology | 2015

von Paul, S. | Klein, K. | Maggs, D. | +1

39

Observational study of kidney function and albuminuria in patients with type 2 diabetes treated with exenatide BID versus insulin glargine

enthalten in: The Annals of pharmacotherapy | 2014

von Pawaskar, M. | Tuttle, K. | Li, Q. | +2

40

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine : achievement of glycemic and cardiovascular goals

enthalten in: Cardiovascular diabetology | 2013

von Meloni, A. | DeYoung, M. | Han, J. | +2